Clinical Trial Update: Interferon Beta in Treating Patients With Metastatic Cutaneous Melanoma or Ocular Melanoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating interferon beta in patients with metastatic cutaneous melanoma or ocular melanoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma
• Ocular Melanoma

Drugs mentioned

• Interferon-beta (interferon beta)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Stage IV Melanoma, Recurrent Melanoma | Phase 2 | Status: COMPLETED